This paper is part of a themed collection on the role of Growth Hormone in Endocrine Cancers. The Guest Editor for this collection was John Kopchick, Ohio University, USA.
Cancer is the second leading cause of death in the United States and among the most prevalent diseases globally, with an incidence expected to grow because of smoking, pollution, poor dietary habits, obesity, and the rise in the older population. Given their ability to reduce risk factors, albeit with varying efficacy, nutrition and fasting could help prevent cancer and other age-related disorders. Calorie restriction (CR), various forms of intermittent fasting (IF) or periodic fasting (PF), and fasting-mimicking diets (FMDs) have been shown to improve health span, increase lifespan, and prevent or postpone cancer in rodents. The effects of specific diets and fasting regimens on aging and cancer appear to be mediated in part by the reduction in the activity of the growth hormone (GH)/insulin-like-growth-factor-I (IGF-1) axis. Nevertheless, recent data indicate that the alternation of low and normal levels of these hormones and factors may be ideal for optimizing longevity and function. Here, we review the role of nutrition, CR, and fasting/FMD on cancer, focusing on the hypothesis that the modulation of GH, IGF-1, and insulin signaling partly mediates the effect of these dietary interventions on cancer prevention.
Endocrine-Related Cancer is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
Sept 2018 onwards | Past Year | Past 30 Days | |
---|---|---|---|
Full Text Views | 197 | 197 | 5 |
PDF Downloads | 252 | 252 | 7 |
Aimaretti G, Colao A, Corneli G, Pivonello R, Maccario M, Morrison K, Pflaum CD, Strasburger CJ, Lombardi G & & Ghigo E 1999 The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults. Clinical Endocrinology 51 771–777. (https://doi.org/10.1046/j.1365-2265.1999.00885.x)
Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S & & Key TJ 2002 The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiology, Biomarkers and Prevention 11 1441–1448.
Amanollahi A, Khazdouz M, Malekahmadi M, Klement RJ, Lee D & & Khodabakhshi A 2023 Effect of ketogenic diets on cardio-metabolic outcomes in cancer patients: a systematic review and meta-analysis of controlled clinical trials. Nutrition and Cancer 75 95–111. (https://doi.org/10.1080/01635581.2022.2117388)
Ananieva EA & & Wilkinson AC 2018 Branched-chain amino acid metabolism in cancer. Current Opinion in Clinical Nutrition and Metabolic Care 21 64–70. (https://doi.org/10.1097/MCO.0000000000000430)
Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hutterer E, Isenring E, Kaasa S, et al.2017 ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition 36 11–48. (https://doi.org/10.1016/j.clnu.2016.07.015)
Argente J, Caballo N, Barrios V, Pozo J, Munoz MT, Chowen JA & & Hernandez M 1997 Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. Journal of Clinical Endocrinology and Metabolism 82 2076–2083. (https://doi.org/10.1210/jcem.82.7.4089)
Argente J, Chowen JA, Perez-Jurado LA, Frystyk J & & Oxvig C 2017 One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiology. EMBO Molecular Medicine 9 1338–1345. (https://doi.org/10.15252/emmm.201707950)
Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavo S, et al.2012 Predictors of morbidity and mortality in acromegaly: an Italian survey. European Journal of Endocrinology 167 189–198. (https://doi.org/10.1530/EJE-12-0084)
Ayuk J & & Sheppard MC 2008 Does acromegaly enhance mortality? Reviews in Endocrine and Metabolic Disorders 9 33–39. (https://doi.org/10.1007/s11154-007-9067-8)
Bach LA 2015 Insulin-like growth factor binding proteins-an update. Pediatric Endocrinology Reviews 13 521–530.
Backeljauw PF . 2001 Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study. Journal of Clinical Endocrinology and Metabolism 86 1504–1510. (https://doi.org/10.1210/jc.86.4.1504)
Bader J, Carson M, Enos R, Velazquez K, Sougiannis A, Singh U, Becker W, Nagarkatti M, Fan D & & Murphy A 2020 High-fat diet-fed ovariectomized mice are susceptible to accelerated subcutaneous tumor growth potentially through adipose tissue inflammation, local insulin-like growth factor release, and tumor associated macrophages. Oncotarget 11 4554–4569. (https://doi.org/10.18632/oncotarget.27832)
Bartke A 2003 Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 78 210–216. (https://doi.org/10.1159/000073704)
Bartke A & & Darcy J 2017 GH and ageing: pitfalls and new insights. Best Practice and Research. Clinical Endocrinology and Metabolism 31 113–125. (https://doi.org/10.1016/j.beem.2017.02.005)
Bartke A, Sun LY & & Longo V 2013 Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. Physiological Reviews 93 571–598. (https://doi.org/10.1152/physrev.00006.2012)
Barzilai N, Huffman DM, Muzumdar RH & & Bartke A 2012 The critical role of metabolic pathways in aging. Diabetes 61 1315–1322. (https://doi.org/10.2337/db11-1300)
Basu R & & Kopchick JJ 2019 The effects of growth hormone on therapy resistance in cancer. Cancer Drug Resistance 2 827–846. (https://doi.org/10.20517/cdr.2019.27)
Basu R & & Kopchick JJ 2023 GH and IGF1 in cancer therapy resistance. Endocrine-Related Cancer 30. (https://doi.org/10.1530/ERC-22-0414)
Basu R, Kulkarni P, Qian YR, Walsh C, Arora P, Davis E, Duran-Ortiz S, Funk K, Ibarra D, Kruse C, et al.2019 Growth hormone upregulates melanocyte-inducing transcription factor expression and activity via JAK2-STAT5 and SRC signaling in GH receptor-positive human melanoma. Cancers 11. (https://doi.org/10.3390/cancers11091352)
Basu R, Qian YR, Mathes S, Terry J, Arnett N, Riddell T, Stevens A, Funk K, Bell S, Bokal Z, et al.2022 Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma in vivo. Frontiers in Oncology 12 (https://doi.org/10.3389/fonc.2022.936145)
Baxter RC 2014 IGF binding proteins in cancer: mechanistic and clinical insights. Nature Reviews. Cancer 14 329–341. (https://doi.org/10.1038/nrc3720)
Bitti SR, Franco M, Albertelli M, Gatto F, Vera L, Ferone D & & Boschetti M 2021 GH replacement in the elderly: is it worth it? Frontiers in Endocrinology 12 680579. (https://doi.org/10.3389/fendo.2021.680579)
Bocharov EV, Lesovoy DM, Bocharova OV, Urban AS, Pavlov KV, Volynsky PE, Efremov RG & & Arseniev AS 2018 Structural basis of the signal transduction via transmembrane domain of the human growth hormone receptor. Biochimica et Biophysica Acta. General Subjects 1862 1410–1420. (https://doi.org/10.1016/j.bbagen.2018.03.022)
Boguszewski CL & & Ayuk J 2016 Management of endocrine disease: acromegaly and cancer: an old debate revisited. European Journal of Endocrinology 175 R147–R156. (https://doi.org/10.1530/EJE-16-0178)
Boguszewski CL & & Boguszewski M 2019a Corrigendum FOR ‘growth hormone’s links to cancer’. Endocrine Reviews 40 1108–1108. (https://doi.org/10.1210/er.2019-00101)
Boguszewski CL & & Boguszewski MCDS 2019b Growth hormone’s links to cancer. Endocrine Reviews 40 558–574. (https://doi.org/10.1210/er.2018-00166)
Bokov AF, Lindsey ML, Khodr C, Sabia MR & & Richardson A 2009 Long-lived Ames dwarf mice are resistant to chemical stressors. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 64 819–827. (https://doi.org/10.1093/gerona/glp052)
Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, Chiavarina B, Frank PG, Flomenberg N, Howell A, Martinez-Outschoorn UE, et al.2010 Ketones and lactate “fuel” tumor growth and metastasis evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 9 3506–3514. (https://doi.org/10.4161/cc.9.17.12731)
Branco AF, Ferreira A, Simoes RF, Magalhaes-Novais S, Zehowski C, Cope E, Silva AM, Pereira D, Sardao VA & & Cunha-Oliveira T 2016 Ketogenic diets: from cancer to mitochondrial diseases and beyond. European Journal of Clinical Investigation 46 285–298. (https://doi.org/10.1111/eci.12591)
Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M, et al.2015 A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metabolism 22 86–99. (https://doi.org/10.1016/j.cmet.2015.05.012)
Brown-Borg HM & & Bartke A 2012 GH and IGF1: roles in energy metabolism of long-living GH mutant mice. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 67 652–660. (https://doi.org/10.1093/gerona/gls086)
Buono R & & Longo VD 2018 Starvation, stress resistance, and cancer. Trends in Endocrinology and Metabolism 29 271–280. (https://doi.org/10.1016/j.tem.2018.01.008)
Buschemeyer WC & & Freedland SJ 2007 Obesity and prostate cancer: epidemiology and clinical implications. European Urology 52 331–343. (https://doi.org/10.1016/j.eururo.2007.04.069)
Caffa I, D'Agostino V, Damonte P, Soncini D, Cea M, Monacelli F, Odetti P, Ballestrero A, Provenzani A, Longo VD, et al.2015 Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition. Oncotarget 6 11820–11832. (https://doi.org/10.18632/oncotarget.3689)
Caffa I, Spagnolo V, Vernieri C, Valdemarin F, Becherini P, Wei M, Brandhorst S, Zucal C, Driehuis E, Ferrando L, et al.2020 Author Correction: fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature 588 E33. (https://doi.org/10.1038/s41586-020-2957-6)
Cairns RA, Harris I, McCracken S & & Mak TW 2011 Cancer cell metabolism. Cold Spring Harbor Symposium of Quantitative Biology 76299–311. (https://doi.org/10.1101/sqb.2011.76.012856)
Caputo M, Pigni S, Agosti E, Daffara T, Ferrero A, Filigheddu N & & Prodam F 2021 Regulation of GH and GH signaling by nutrients. Cells 10. (https://doi.org/10.3390/cells10061376)
Casanueva FF, Villanueva L, Dieguez C, Diaz Y, Cabranes JA, Szoke B, Scanlon MF, Schally AV & & Fernandezcruz A 1987 Free fatty-acids block growth-hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. Journal of Clinical Endocrinology and Metabolism 65 634–642. (https://doi.org/10.1210/jcem-65-4-634)
Cavuoto P & & Fenech MF 2012 A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension. Cancer Treatment Reviews 38 726–736. (https://doi.org/10.1016/j.ctrv.2012.01.004)
Chanson P & & Salenave S 2008 Acromegaly. Orphanet Journal of Rare Diseases 3 17. (https://doi.org/10.1186/1750-1172-3-17)
Chaturvedi S, Hoffman RM & & Bertino JR 2018 Exploiting methionine restriction for cancer treatment. Biochemical Pharmacology 154 170–173. (https://doi.org/10.1016/j.bcp.2018.05.003)
Chen YJ, Zhang X, Wu ZS, Wang JJ, Lau AYC, Zhu T & & Lobie PE 2015 Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells. Cancer Letters 365 182–189. (https://doi.org/10.1016/j.canlet.2015.05.031)
Chhabra Y, Nelson CN, Plescher M, Barclay JL, Smith AG, Andrikopoulos S, Mangiafico S, Waxman DJ, Brooks AJ & & Waters MJ 2019 Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity. FASEB Journal 33 6412–6430. (https://doi.org/10.1096/fj.201802328R)
Chhabra Y, Waters MJ & & Brooks AJ 2011 Role of the growth hormone-IGF-1 axis in cancer. Expert Review of Endocrinology and Metabolism 6 71–84. (https://doi.org/10.1586/eem.10.73)
Chiarelli F, Giannini C & & Mohn A 2004 Growth, growth factors and diabetes. European Journal of Endocrinology 151(Supplement 3) U109–U117. (https://doi.org/10.1530/eje.0.151u109)
Chitnis MM, Lodhia KA, Aleksic T, Gao S, Protheroe AS & & Macaulay VM 2014 IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination. Oncogene 33 5262–5273. (https://doi.org/10.1038/onc.2013.460)
Chung YW, Han DS, Park YK, Son BK, Paik CH, Jeon YC & & Sohn JH 2006 Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Gastrointestinal Endoscopy 63 AB212–AB212.
Cohen CW, Fontaine KR, Arend RC, Alvarez RD, Leath CA, Huh WK, Bevis KS, Kim KH, Straughn JM & & Gower BA 2018 A ketogenic diet reduces central obesity and serum insulin in women with ovarian or endometrial cancer. Journal of Nutrition 148 1253–1260. (https://doi.org/10.1093/jn/nxy119)
Cohen P 2006 Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age. Endocrinology 147 2109–2111. (https://doi.org/10.1210/en.2006-0195)
Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM & 2007 ISS Consensus Workshop participants 2008 . Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the growth hormone research society, the Lawson Wilkins Pediatric endocrine society, and the European society for paediatric endocrinology workshop. Journal of Clinical Endocrinology and Metabolism 93 4210–4217. (https://doi.org/10.1210/jc.2008-0509)
Cornford AS, Barkan AL & & Horowitz JF 2011 Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 96 824–830. (https://doi.org/10.1210/jc.2010-1895)
Cortellino S, Raveane A, Chiodoni C, Delfanti G, Pisati F, Spagnolo V, Visco E, Fragale G, Ferrante F, Magni S, et al.2022 Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects. Cell Reports 40 111256. (https://doi.org/10.1016/j.celrep.2022.111256)
Coschigano KT, Clemmons D, Bellush LL & & Kopchick JJ 2000 Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141 2608–2613. (https://doi.org/10.1210/endo.141.7.7586)
Counts DR, Gwirtsman H, Carlsson LMS, Lesem M & & Cutler GB 1992 The effect of anorexia-nervosa and refeeding on growth hormone-binding protein, the insulin-like growth-factors (IGFS), and the IGF-binding proteins. Journal of Clinical Endocrinology and Metabolism 75 762–767. (https://doi.org/10.1210/jcem.75.3.1381372)
Crowe FL, Key TJ, Allen NE, Appleby PN, Roddam A, Overvad K, Gronbaek H, Tjonneland A, Halkjaer J, Dossus L, et al.2009 The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European prospective investigation into cancer and nutrition. Cancer Epidemiology, Biomarkers and Prevention 18 1333–1340. (https://doi.org/10.1158/1055-9965.EPI-08-0781)
Cummings NE, Williams EM, Kasza I, Konon EN, Schaid MD, Schmidt BA, Poudel C, Sherman DS, Yu DY, Apelo SIA, et al.2018 Restoration of metabolic health by decreased consumption of branched-chain amino acids. Journal of Physiology 596 623–645. (https://doi.org/10.1113/JP275075)
de Groot S, Lugtenberg RT, Cohen D, Welters MJP, Ehsan I, Vreeswijk MPG, Smit V, de Graaf H, Heijns JB, Portielje JEA, et al.2020 Fasting mimicking diet as an adjunct toneoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nature Communications 11 3083. (https://doi.org/10.1038/s41467-020-16138-3)
de Groot S, Pijl H, van der Hoeven JJM & & Kroep JR 2019 Effects of short-term fasting on cancer treatment. Journal of Experimental and Clinical Cancer Research 38 209. (https://doi.org/10.1186/s13046-019-1189-9)
De Pergola G & & Silvestris F 2013 Obesity as a major risk factor for cancer. Journal of Obesity 2013 291546. (https://doi.org/10.1155/2013/291546)
Di Biase S & & Longo VD 2016 Fasting-induced differential stress sensitization in cancer treatment. Molecular and Cellular Oncology 3 e1117701. (https://doi.org/10.1080/23723556.2015.1117701)
Di Tano M, Raucci F, Vernieri C, Caffa I, Buono R, Fanti M, Brandhorst S, Curigliano G, Nencioni A, de Braud F, et al.2020 Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers. Nature Communications 11 2332. (https://doi.org/10.1038/s41467-020-16243-3)
Dimaraki EV & & Jaffe CA 2006 Role of endogenous ghrelin in growth hormone secretion, appetite regulation and metabolism. Reviews in Endocrine and Metabolic Disorders 7 237–249. (https://doi.org/10.1007/s11154-006-9022-0)
Divisova J, Kuiatse I, Lazard Z, Weiss H, Vreeland F, Hadsell DL, Schiff R, Osborne CK & & Lee AV 2006 The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth. Breast Cancer Research and Treatment 98 315–327. (https://doi.org/10.1007/s10549-006-9168-1)
Dominick G, Berryman DE, List EO, Kopchick JJ, Li XN, Miller RA & & Garcia GG 2015 Regulation of mTOR activity in Snell dwarf and GH receptor gene-disrupted mice. Endocrinology 156 565–575. (https://doi.org/10.1210/en.2014-1690)
Duggan C, Wang CY, Neuhouser ML, Xiao LR, Smith AW, Reding KW, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R, et al.2013 Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer. International Journal of Cancer 132 1191–1200. (https://doi.org/10.1002/ijc.27753)
Durai R, Yang WX, Gupta S, Seifalian AM & & Winslet MC 2005 The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. International Journal of Colorectal Disease 20 203–220. (https://doi.org/10.1007/s00384-004-0675-4)
Duran-Ortiz S, List EO, Ikeno Y, Young J, Basu R, Bell S, McHugh T, Funk K, Mathes S, Qian YR, et al.2021 Growth hormone receptor gene disruption in mature-adult mice improves male insulin sensitivity and extends female lifespan. Aging Cell 20 e13506. (https://doi.org/10.1111/acel.13506)
Ernst M & & Rodan GA 1990 Increased activity of insulin-like growth-factor (IGF) in osteoblastic cells in the presence of growth-hormone (GH) - positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127 807–814. (https://doi.org/10.1210/endo-127-2-807)
Eugster EA & & Pescovitz OH 1999 Commentary - Gigantism. Journal of Clinical Endocrinology and Metabolism 84 4379–4384. (https://doi.org/10.1210/jcem.84.12.6222)
Fazeli PK & & Klibanski A 2014 Determinants of GH resistance in malnutrition. Journal of Endocrinology 220 R57–R65. (https://doi.org/10.1530/JOE-13-0477)
Flurkey K, Papaconstantinou J, Miller RA & & Harrison DE 2001 Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proceedings of the National Academy of Sciences of the United States of America 98 6736–6741. (https://doi.org/10.1073/pnas.111158898)
Fontana L, Partridge L & & Longo VD 2010 Extending healthy life span-from yeast to humans. Science 328 321–326. (https://doi.org/10.1126/science.1172539)
Fontana L, Weiss EP, Villareal DT, Klein S & & Holloszy JO 2008 Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell 7 681–687. (https://doi.org/10.1111/j.1474-9726.2008.00417.x)
Frystyk J, Delhanty PJD, Skjaerbaek C & & Baxter RC 1999 Changes in the circulating IGF system during short-term fasting and refeeding in rats. American Journal of Physiology 277 E245–E252. (https://doi.org/10.1152/ajpendo.1999.277.2.E245)
Garg SK, Ritchie PJ, Moser EG, Snell-Bergeon JK, Freson BJ & & Hazenfield RM 2011 Effects of colesevelam on LDL-C, A1c and GLP-1 levels in patients with type 1 diabetes: a pilot randomized double-blind trial. Diabetes, Obesity and Metabolism 13 137–143. (https://doi.org/10.1111/j.1463-1326.2010.01320.x)
Gebre-Medhin M, Kindblom LG, Wennbo H, Tornell J & & Meis-Kindblom JM 2001 Growth hormone receptor is expressed in human breast cancer. American Journal of Pathology 158 1217–1222. (https://doi.org/10.1016/S0002-9440(1064071-0)
Gilbert CA & & Slingerland JM 2013 Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annual Review of Medicine 64 45–57. (https://doi.org/10.1146/annurev-med-121211-091527)
Giovannucci E 2001 Insulin, insulin-like growth factors and colon cancer: a review of the evidence. Journal of Nutrition 131(11 Supplement) 3109S–3120S. (https://doi.org/10.1093/jn/131.11.3109S)
Glass AR, Burman KD, Dahms WT & & Boehm TM 1981 Endocrine function in human obesity. Metabolism: Clinical and Experimental 30 89–104. (https://doi.org/10.1016/0026-0495(8190224-9)
Grey A, Chen Q, Xu X, Callon K & & Cornish J 2003 Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells. Endocrinology 144 4886–4893. (https://doi.org/10.1210/en.2003-0350)
Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, Hwang D, Martin-Montalvo A, Saavedra J, Ingles S, et al.2011 Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Science Translational Medicine 3 70ra13. (https://doi.org/10.1126/scitranslmed.3001845)
Guevara-Aguirre J, Guevara A, Palacios I, Perez M, Procel P & & Teran E 2018 GH and GHR signaling in human disease. Growth Hormone and IGF Research 38 34–38. (https://doi.org/10.1016/j.ghir.2017.12.006)
Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Howard BV, Wylie-Rosett J, Anderson GL, Ho GYF, et al.2008 Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Research 68 329–337. (https://doi.org/10.1158/0008-5472.CAN-07-2946)
Hartman ML, Clayton PE, Johnson ML, Celniker A, Perlman AJ, Alberti KG & & Thorner MO 1993 A low-dose euglycemic infusion of recombinant human insulin-like growth factor-I rapidly suppresses fasting-enhanced pulsatile growth-hormone secretion in humans. Journal of Clinical Investigation 91 2453–2462. (https://doi.org/10.1172/JCI116480)
Hartman ML, Veldhuis JD, Johnson ML, Lee MM, Alberti KG, Samojlik E & & Thorner MO 1992 Augmented growth-hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during A 2-day fast in normal men. Journal of Clinical Endocrinology and Metabolism 74 757–765. (https://doi.org/10.1210/jcem.74.4.1548337)
Hartman ML, Veldhuis JD & & Thorner MO 1993 Normal control of growth-hormone secretion. Hormone Research 40 37–47. (https://doi.org/10.1159/000183766)
Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG & & Thorner MO 1988 Fasting enhances growth-hormone secretion and amplifies the complex rhythms of growth-hormone secretion in man. Journal of Clinical Investigation 81 968–975. (https://doi.org/10.1172/JCI113450)
Ho PJ, Friberg RD & & Barkan AL 1992 Regulation of pulsatile growth-hormone secretion by fasting in normal subjects and patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 75 812–819. (https://doi.org/10.1210/jcem.75.3.1517371)
Holdaway IM, Bolland MJ & & Gamble GD 2008 A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. European Journal of Endocrinology 159 89–95. (https://doi.org/10.1530/EJE-08-0267)
Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P & & Le Bouc Y 2003 IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421 182–187. (https://doi.org/10.1038/nature01298)
Hoppe C, Molgaard C & & Michaelsen KF 2006 Cow's milk and linear growth in industrialized and developing countries. Annual Review of Nutrition 26 131–173. (https://doi.org/10.1146/annurev.nutr.26.010506.103757)
Ikeno Y, Bronson RT, Hubbard GB, Lee S & & Bartke A 2003 Delayed occurrence of fatal neoplastic diseases in Ames dwarf mice: correlation to extended longevity. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 58 291–296. (https://doi.org/10.1093/gerona/58.4.b291)
Ikeno Y, Hubbard GB, Lee S, Cortez LA, Lew CM, Webb CR, Berryman DE, List EO, Kopchick JJ & & Bartke A 2009 Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 64 522–529. (https://doi.org/10.1093/gerona/glp017)
Imae M, Fu Z, Yoshida A, Noguchi T & & Kato H 2003 Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16. Journal of Molecular Endocrinology 30 253–262. (https://doi.org/10.1677/jme.0.0300253)
Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ & & Kliewer SA 2008 Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metabolism 8 77–83. (https://doi.org/10.1016/j.cmet.2008.05.006)
Iranmanesh A & & Veldhuis JD 1992 Clinical pathophysiology of the somatotropic (GH) axis in adults. Endocrinology and Metabolism Clinics of North America 21 783–816. (https://doi.org/10.1016/S0889-8529(1830189-0)
Izzard AS, Emerson M, Prehar S, Neyses L, Trainer P, List EO, Kopchick JJ & & Heagerty AM 2009 The cardiovascular phenotype of a mouse model of acromegaly. Growth Hormone and IGF Research 19 413–419. (https://doi.org/10.1016/j.ghir.2008.12.006)
Jeon H, Kim JH, Lee E, Jang YJ, Son JE, Kwon JY, Lim TG, Kim S, Park JHY, Kim JE, et al.2016 Methionine deprivation suppresses triple-negative breast cancer metastasis in vitro and in vivo. Oncotarget 7 67223–67234. (https://doi.org/10.18632/oncotarget.11615)
Junnila RK, List EO, Berryman DE, Murrey JW & & Kopchick JJ 2013 The GH/IGF-1 axis in ageing and longevity. Nature Reviews. Endocrinology 9 366–376. (https://doi.org/10.1038/nrendo.2013.67)
Kakkoura MG, Du H, Guo Y, Yu C, Yang L, Pei P, Chen Y, Sansome S, Chan WC, Yang X, et al.2022 Dairy consumption and risks of total and site-specific cancers in Chinese adults: an 11-year prospective study of 0.5 million people. BMC Medicine 20 134. (https://doi.org/10.1186/s12916-022-02330-3)
Kaplan SA & & Cohen P 2007 Review: the somatomedin hypothesis 2007: 50 years later. Journal of Clinical Endocrinology and Metabolism 92 4529–4535. (https://doi.org/10.1210/jc.2007-0526)
Ketelslegers JM, Maiter D, Maes M, Underwood LE & & Thissen JP 1995 Nutritional regulation of insulin-like growth-factor-I. Metabolism: Clinical and Experimental 44(Supplement 4) 50–57. (https://doi.org/10.1016/0026-0495(9590221-x)
Khatib N, Gaidhane S, Gaidhane AM, Khatib M, Simkhada P, Gode D & & Zahiruddin QS 2014 Ghrelin: ghrelin as a regulatory peptide in growth hormone secretion. Journal of Clinical and Diagnostic Research 8 MC13–MC17. (https://doi.org/10.7860/JCDR/2014/9863.4767)
Klement RJ 2019 The emerging role of ketogenic diets in cancer treatment. Current Opinion in Clinical Nutrition and Metabolic Care 22 129–134. (https://doi.org/10.1097/MCO.0000000000000540)
Klement RJ & & Fink MK 2016 Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer. Oncogenesis 5 e193. (https://doi.org/10.1038/oncsis.2016.2)
Klement RJ, Meyer D, Kanzler S & & Sweeney RA 2022 Ketogenic diets consumed during radio-chemotherapy have beneficial effects on quality of life and metabolic health in patients with rectal cancer. European Journal of Nutrition 61 69–84. (https://doi.org/10.1007/s00394-021-02615-y)
Knuppel A, Fensom GK, Watts EL, Gunter MJ, Murphy N, Papier K, Perez-Cornago A, Schmidt JA, Byrne KS, Travis RC, et al.2020 Circulating insulin-like growth factor-I concentrations and risk of 30 cancers: prospective analyses in UK Biobank. Cancer Research 80 4014–4021. (https://doi.org/10.1158/0008-5472.CAN-20-1281)
Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, et al.2003 Growth hormone insensitivity associated with a STAT5b mutation. New England Journal of Medicine 349 1139–1147. (https://doi.org/10.1056/NEJMoa022926)
Komninou D, Leutzinger Y, Reddy BS & & Richie JP 2006 Methionine restriction inhibits colon carcinogenesis. Nutrition and Cancer 54 202–208. (https://doi.org/10.1207/s15327914nc5402_6)
Kopchick JJ, List EO, Kelder B, Gosney ES & & Berryman DE 2014 Evaluation of growth hormone (GH) action in mice: discovery of GH receptor antagonists and clinical indications. Molecular and Cellular Endocrinology 386 34–45. (https://doi.org/10.1016/j.mce.2013.09.004)
Kopchick JJ, Parkinson C, Stevens EC & & Trainer PJ 2002 Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocrine Reviews 23 623–646. (https://doi.org/10.1210/er.2001-0022)
Lapkina-Gendler L, Rotem I, Pasmanik-Chor M, Gurwitz D, Sarfstein R, Laron Z & & Werner H 2016 Identification of signaling pathways associated with cancer protection in Laron syndrome. Endocrine-Related Cancer 23 399–410. (https://doi.org/10.1530/ERC-16-0054)
Laron Z, Pertzelan A & & Mannheimer S 1966 Genetic pituitary dwarfism with high serum concentration of growth hormone in a new inborn error of metabolism. Israel Journal of Medical Sciences 2 152–155.
Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A, Pistoia V, Wei M, Hwang S, Merlino A, et al.2012 Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Science Translational Medicine 4 124ra27. (https://doi.org/10.1126/scitranslmed.3003293)
Lee CH, Safdie FM, Raffaghello L, Wei M, Madia F, Parrella E, Hwang D, Cohen P, Bianchi G & & Longo VD 2010 Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Research 70 1564–1572. (https://doi.org/10.1158/0008-5472.CAN-09-3228)
Lee DH, Fung TT, Tabung FK, Colditz GA, Ghobrial IM, Rosner BA, Giovannucci EL & & Birmann BM 2019 Dietary pattern and risk of multiple myeloma in two large prospective US cohort studies. JNCI Cancer Spectrum 3 pkz025. (https://doi.org/10.1093/jncics/pkz025)
Lee DH, Tabung FK & & Giovannucci EL 2022 Association of animal and plant protein intakes with biomarkers of insulin and insulin-like growth factor axis. Clinical Nutrition 41 1272–1280. (https://doi.org/10.1016/j.clnu.2022.04.003)
Levine ME, Suarez JA, Brandhorst S, Balasubramanian P, Cheng CW, Madia F, Fontana L, Mirisola MG, Guevara-Aguirre J, Wan J, et al.2014 Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metabolism 19 407–417. (https://doi.org/10.1016/j.cmet.2014.02.006)
Li R, Ferreira MP, Cooke MB, La Bounty P, Campbell B, Greenwood M, Willoughby DS & & Kreider RB 2015 Co-ingestion of carbohydrate with branched-chain amino acids or lleucine does not preferentially increase serum IGF-1 and expression of myogenic-related genes in response to a single bout of resistance exercise. Amino Acids 47 1203–1213. (https://doi.org/10.1007/s00726-015-1947-8)
Li S, Crenshaw EB, Rawson EJ, Simmons DM, Swanson LW & & Rosenfeld MG 1990 Dwarf locus mutants lacking 3 pituitary cell-types result from mutations in the POU-domain gene PIT-1. Nature 347 528–533. (https://doi.org/10.1038/347528a0)
Li ZQ, Ji BW, Dixit PD, Tchourine K, Lien EC, Hosios AM, Abbott KL, Rutter JC, Westermark AM, Gorodetsky EF, et al.2022 Cancer cells depend on environmental lipids for proliferation when electron acceptors are limited. Nature Metabolism 4 711–723. (https://doi.org/10.1038/s42255-022-00588-8)
Ligorio F, Fuca G, Provenzano L, Lobefaro R, Zanenga L, Vingiani A, Belfiore A, Lorenzoni A, Alessi A, Pruneri G, et al.2022 Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: a sub- analysis of the NCT03340935 trial. European Journal of Cancer 172 300–310. (https://doi.org/10.1016/j.ejca.2022.05.046)
List EO, Berryman DE, Buchman M, Jensen EA, Funk K, Duran-Ortiz S, Qian YR, Young JA, Slyby J, McKenna S, et al.2019 GH knockout mice have increased subcutaneous adipose tissue with decreased fibrosis and enhanced insulin sensitivity. Endocrinology 160 1743–1756. (https://doi.org/10.1210/en.2019-00167)
Liu B, Giffney HE, Arthur RS, Rohan TE & & Dannenberg AJ 2021 Cancer risk in normal weight individuals with metabolic obesity: a narrative review. Cancer Prevention Research 14 509–520. (https://doi.org/10.1158/1940-6207.CAPR-20-0633)
L-López F, Sarmento-Cabral A, Herrero-Aguayo V, Gahete MD, Castaño JP & & Luque RM 2017 . Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1. Journal of Cellular and Molecular Medicine 21 1893–1904. (https://doi.org/10.1111/jcmm.13109)
Loeper S & & Ezzat S 2008 Acromegaly: re-thinking the cancer risk. Reviews in Endocrine and Metabolic Disorders 9 41–58. (https://doi.org/10.1007/s11154-007-9063-z)
Longo VD & & Mattson MP 2014 Fasting: molecular mechanisms and clinical applications. Cell Metabolism 19 181–192. (https://doi.org/10.1016/j.cmet.2013.12.008)
Lu M, Flanagan JU, Langley RJ, Hay MP & & Perry JK 2019 Targeting growth hormone function: strategies and therapeutic applications. Signal Transduction and Targeted Therapy 4 3. (https://doi.org/10.1038/s41392-019-0036-y)
Maccario M, Aimaretti G, Grottoli S, Gauna C, Tassone F, Corneli G, Rossetto R, Wu Z, Strasburger CJ & & Ghigo E 2001 Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. International Journal of Obesity and Related Metabolic Disorders 25 1233–1239. (https://doi.org/10.1038/sj.ijo.0801671)
Mahoney LB, Denny CA & & Seyfried TN 2006 Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans. Lipids in Health and Disease 5 13. (https://doi.org/10.1186/1476-511X-5-13)
Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P & Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials 2004 Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. Journal of Clinical Endocrinology and Metabolism 89 2192–2199. (https://doi.org/10.1210/jc.2003-030840)
Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A & & Asselain B 2008 Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Research and Treatment 111 329–342. (https://doi.org/10.1007/s10549-007-9785-3)
Marker PC, Unterberger CJ & & Swanson SM 2023 GH-dependent growth of experimentally induced carcinomas in vivo. Endocrine-Related Cancer 30 e220403. (https://doi.org/10.1530/ERC-22-0403)
Matsuzaki J, Kuwamura M, Yamaji R, Inui H & & Nakano Y 2001 Inflammatory responses to lipopolysaccharide are suppressed in 40% energy-restricted mice. Journal of Nutrition 131 2139–2144. (https://doi.org/10.1093/jn/131.8.2139)
Mayers JR, Wu C, Clish CB, Kraft P, Torrence ME, Fiske BP, Yuan C, Bao Y, Townsend MK, Tworoger SS, et al.2014 Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nature Medicine 20 1193–1198. (https://doi.org/10.1038/nm.3686)
McCarty MF, Barroso-Aranda J & & Contreras F 2009 The low-methionine content of vegan diets may make methionine restriction feasible as a life extension strategy. Medical Hypotheses 72 125–128. (https://doi.org/10.1016/j.mehy.2008.07.044)
Melmed S 2009 Acromegaly pathogenesis and treatment. Journal of Clinical Investigation 119 3189–3202. (https://doi.org/10.1172/JCI39375)
Melnik BC, John SM & & Schmitz G 2011 Over-stimulation of insulin/IGF-1 signaling by western diet may promote diseases of civilization: lessons learnt from Laron syndrome. Nutrition and Metabolism 8 41. (https://doi.org/10.1186/1743-7075-8-41)
Menashe I, Maeder D, Garcia-Closas M, Figueroa JD, Bhattacharjee S, Rotunno M, Kraft P, Hunter DJ, Chanock SJ, Rosenberg PS, et al.2010 Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Research 70 4453–4459. (https://doi.org/10.1158/0008-5472.CAN-09-4502)
Mercado M, Gonzalez B, Vargas G, Ramirez C, Monteros ALE, Sosa E, Jervis P, Roldan P, Mendoza V, Lopez-Felix B, et al.2014 Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. Journal of Clinical Endocrinology and Metabolism 99 4438–4446. (https://doi.org/10.1210/jc.2014-2670)
Miquet JG, Freund T, Martinez CS, Gonzalez L, Diaz ME, Micucci GP, Zotta E, Boparai RK, Bartke A, Turyn D, et al.2013 Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone. Cell Cycle 12 1042–1057. (https://doi.org/10.4161/cc.24026)
Moller N & & Jorgensen JOL 2009 Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews 30 152–177. (https://doi.org/10.1210/er.2008-0027)
Moore JP, Morrison DG & & Hyde JF 1994 Galanin gene-expression is increased in the anterior-pituitary gland of the human growth hormone-releasing hormone transgenic mouse. Endocrinology 134 2005–2010. (https://doi.org/10.1210/endo.134.5.7512494)
Murphy N, Carreras-Torres R, Song MY, Chan AT, Martin RM, Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Bradbury KE, et al.2020 Circulating levels of insulin-like growth factor 1 and insulin-like growth factor binding Protein 3 associate with risk of colorectal cancer based on serologic and Mendelian randomization analyses. Gastroenterology 158 1300–1312.e20. (https://doi.org/10.1053/j.gastro.2019.12.020)
Neely RDG, Rooney DP, Bell PM, Bell NP, Sheridan B, Atkinson AB & & Trimble ER 1992 Influence of growth-hormone on glucose-glucose 6-phosphate cycle and insulin action in normal humans. American Journal of Physiology 263 E980–E987. (https://doi.org/10.1152/ajpendo.1992.263.5.E980)
Nencioni A, Caffa I, Cortellino S & & Longo VD 2018 Fasting and cancer: molecular mechanisms and clinical application. Nature Reviews. Cancer 18 707–719. (https://doi.org/10.1038/s41568-018-0061-0)
Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, et al.2009 A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism 9 311–326. (https://doi.org/10.1016/j.cmet.2009.02.002)
Orgeron ML, Stone KP, Wanders D, Cortez CC, Van NT & & Gettys TW 2014 The impact of dietary methionine restriction on biomarkers of metabolic health .Glucose Homeostatis and the Pathogenesis of Diabetes Mellitus 121 351–376.
Ouchi N, Parker JL, Lugus JJ & & Walsh K 2011 Adipokines in inflammation and metabolic disease. Nature Reviews. Immunology 11 85–97. (https://doi.org/10.1038/nri2921)
Park SE, Chung HY & & Park YJ 2017 Calorie restriction facilitates aging-related muscle loss in the aged mice. FASEB Journal 31. (https://doi.org/10.1096/fasebj.31.1_supplement.lb306)
Pollak M, Blouin MJ, Zhang JC & & Kopchick JJ 2001 Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist. British Journal of Cancer 85 428–430. (https://doi.org/10.1054/bjoc.2001.1895)
Pombo M, Pombo CM, Garcia A, Caminos E, Gualillo O, Alvarez CV, Casanueva FF & & Dieguez C 2001 Hormonal control of growth hormone secretion. Hormone Research 55(Supplement 1) 11–16. (https://doi.org/10.1159/000063456)
Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G & & Longo VD 2008 Starvation-dependent differential stress resistance protects normal but not cancer COS against high-dose chemotherapy. Proceedings of the National Academy of Sciences of the United States of America 105 8215–8220. (https://doi.org/10.1073/pnas.0708100105)
Rahmani J, Montesanto A, Giovannucci E, Zand H, Barati M, Kopchick JJ, Mirisola MG, Lagani V, Bawadi H, Vardavas R, et al.2022 Association between IGF-1 levels ranges and all-cause mortality: a meta-analysis. Aging Cell 21 e13540. (https://doi.org/10.1111/acel.13540)
Resnicoff M, Burgaud JL, Rotman HL, Abraham D & & Baserga R 1995 Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth-factor-I receptors. Cancer Research 55 3739–3741.
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, et al.2008 Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Annals of Internal Medicine 149 461–W488. (https://doi.org/10.7326/0003-4819-149-7-200810070-00006)
Rosenfeld RG 2005 The molecular basis of idiopathic short stature. Growth Hormone and IGF Research 15(Supplement A) S3–S5. (https://doi.org/10.1016/j.ghir.2005.06.014)
Safdie F, Brandhorst S, Wei M, Wang WJ, Lee C, Hwang S, Conti PS, Chen TC & & Longo VD 2012 Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One 7 e44603. (https://doi.org/10.1371/journal.pone.0044603)
Salvadori G, Mirisola MG & & Longo VD 2021 Intermittent and periodic fasting, hormones, and cancer prevention. Cancers 13. (https://doi.org/10.3390/cancers13184587)
Sans MD, Lee SH, D'Alecy LG & & Williams JA 2004 Feeding activates protein synthesis in mouse pancreas at the translational level without increase in mRNA. American Journal of Physiology-Gastrointestinal and Liver Physiology 287 G667–G675. (https://doi.org/10.1152/ajpgi.00505.2003)
Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A & & Savage PJ 1999 Increased blood glucose and insulin, body size, and incident colorectal cancer. Journal of the National Cancer Institute 91 1147–1154. (https://doi.org/10.1093/jnci/91.13.1147)
Sethi JK & & Vidal-Puig AJ 2007 Thematic review series: adipocyte biology - adipose tissue function and plasticity orchestrate nutritional adaptation. Journal of Lipid Research 48 1253–1262. (https://doi.org/10.1194/jlr.R700005-JLR200)
Shevah O & & Laron Z 2007 Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Hormone and IGF Research 17 54–57. (https://doi.org/10.1016/j.ghir.2006.10.007)
Siddle K 2011 Signalling by insulin and IGF receptors: supporting acts and new players. Journal of Molecular Endocrinology 47 R1–R10. (https://doi.org/10.1530/JME-11-0022)
Sinha R, Cooper TK, Rogers CJ, Sinha I, Turbitt WJ, Calcagnotto A, Perrone CE & & Richie JP 2014 Dietary methionine restriction inhibits prostatic intraepithelial neoplasia in TRAMP mice. Prostate 74 1663–1673. (https://doi.org/10.1002/pros.22884)
Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG & & Jansson JO 1999 Liver-derived IGF-I regulates GH-secretion but is not required for postnatal body growth. Journal of Bone and Mineral Research 14 S192–S192.
Snibson KJ, Bhathal PS & & Adams TE 2001 Overexpressed growth hormone (GH) synergistically promotes carcinogen initiated liver tumour growth by promoting cellular proliferation in emerging hepatocellular neoplasms in female and male GH transgenic mice. Liver 21 149–158. (https://doi.org/10.1034/j.1600-0676.2001.021002149.x)
Sparano JA, Wang ML, Zhao FM, Stearns V, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge GW, et al.2012 Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 118 5937–5946. (https://doi.org/10.1002/cncr.27527)
Sperry J, Condro MC, Guo L, Braas D, Vanderveer-Harris N, Kim KKO, Pope WB, Divakaruni AS, Lai A, Christofk H, et al.2020 Glioblastoma utilizes fatty acids and ketone bodies for growth allowing progression during ketogenic diet therapy. iScience 23 101453. (https://doi.org/10.1016/j.isci.2020.101453)
Steuerman R, Shevah O & & Laron Z 2011 Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. European Journal of Endocrinology 164 485–489. (https://doi.org/10.1530/EJE-10-0859)
Steyn FJ, Tolle V, Chen C & & Epelbaum J 2016 Neuroendocrine regulation of growth hormone secretion. Comprehensive Physiology 6 687–735. (https://doi.org/10.1002/cphy.c150002)
Steyn FJ, Xie TY, Huang L, Ngo ST, Veldhuis JD, Waters MJ & & Chen C 2013 Increased adiposity and insulin correlates with the progressive suppression of pulsatile GH secretion during weight gain. Journal of Endocrinology 218 233–244. (https://doi.org/10.1530/JOE-13-0084)
Subramani R, Nandy SB, Pedroza DA & & Lakshmanaswamy R 2017 Role of growth hormone in breast cancer. Endocrinology 158 1543–1555. (https://doi.org/10.1210/en.2016-1928)
Tabung FK, Wang W, Fung TT, Hu FB, Smith-Warner SA, Chavarro JE, Fuchs CS, Willett WC & & Giovannucci EL 2016 Development and validation of empirical indices to assess the insulinaemic potential of diet and lifestyle. British Journal of Nutrition 116 1787–1798. (https://doi.org/10.1017/S0007114516003755)
Tabung FK, Wang W, Fung TT, Smith-Warner SA, Keum N, Wu K, Fuchs CS, Hu FB & & Giovannucci EL 2018 Association of dietary insulinemic potential and colorectal cancer risk in men and women. American Journal of Clinical Nutrition 108 363–370. (https://doi.org/10.1093/ajcn/nqy093)
Tajan M & & Vousden KH 2020 Dietary approaches to cancer therapy. Cancer Cell 37 767–785. (https://doi.org/10.1016/j.ccell.2020.04.005)
Thissen JP, Ketelslegers JM & & Underwood LE 1994 Nutritional regulation of the insulin-like growth-factors. Endocrine Reviews 15 80–101. (https://doi.org/10.1210/edrv-15-1-80)
Tornell J, Carlsson B, Pohjanen P, Wennbo H, Rymo L & & Isaksson O 1992 High-frequency of mammary adenocarcinomas in metallothionein promoter-human growth-hormone transgenic mice created from 2 different strains of mice. Journal of Steroid Biochemistry and Molecular Biology 43 237–242. (https://doi.org/10.1016/0960-0760(9290213-3)
Trepanowski JF, Canale RE, Marshall KE, Kabir MM & & Bloomer RJ 2011 Impact of caloric and dietary restriction regimens on markers of health and longevity in humans and animals: a summary of available findings. Nutrition Journal 10 107. (https://doi.org/10.1186/1475-2891-10-107)
Tucker LA, Erickson A, LeCheminant JD & & Bailey BW 2015 Dairy consumption and insulin resistance: the role of body fat, physical activity, and energy intake. Journal of Diabetes Research 2015 206959. (https://doi.org/10.1155/2015/206959)
Uehara H, Kobayashi T, Matsumoto M, Watanabe S, Yoneda A & & Bando Y 2018 Adipose tissue : critical contributor to the development of prostate cancer. Journal of Medical Investigation 65 9–17. (https://doi.org/10.2152/jmi.65.9)
van den Top M, Lee K, Whyment AD, Blanks AM & & Spanswick D 2004 Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nature Neuroscience 7 493–494. (https://doi.org/10.1038/nn1226)
Vance ML, Hartman ML & & Thorner MO 1992 Growth-hormone and nutrition. Hormone Research 38(Supplement 1) 85–88. (https://doi.org/10.1159/000182577)
Vazquez-Borrego MC, Gahete MD, Martinez-Fuentes AJ, Fuentes-Fayos AC, Castano JP, Kineman RD & & Luque RM 2018 Multiple signaling pathways convey central and peripheral signals to regulate pituitary function: lessons from human and non-human primate models. Molecular and Cellular Endocrinology 463 4–22. (https://doi.org/10.1016/j.mce.2017.12.007)
Vergara M, Smith-Wheelock M, Harper JM, Sigler R & & Miller RA 2004 Hormone-treated snell dwarf mice regain fertility but remain long lived and disease resistant. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 59 1244–1250. (https://doi.org/10.1093/gerona/59.12.1244)
Wang ZH, Prins GS, Coschigano KT, Kopchick JJ, Green JE, Ray VH, Hedayat S, Christov KT, Unterman TG & & Swanson SM 2005 Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse. Endocrinology 146 5188–5196. (https://doi.org/10.1210/en.2005-0607)
Wei M, Brandhorst S, Shelehchi M, Mirzaei H, Cheng CW, Budniak J, Groshen S, Mack WJ, Guen E, Di Biase S, et al.2017 Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Science Translational Medicine 9. (https://doi.org/10.1126/scitranslmed.aai8700)
Werner H, Sarfstein R & & Bruchim I 2019 Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy. Expert Opinion on Investigational Drugs 28 1101–1112. (https://doi.org/10.1080/13543784.2019.1694660)
Werner H, Sarfstein R, Nagaraj K & & Laron Z 2020 Laron syndrome research paves the way for new insights in oncological investigation. Cells 9. (https://doi.org/10.3390/cells9112446)
Werner H, Shalita-Chesner M, Abramovitch S, Idelman G, Shaharabani-Gargir L & & Glaser T 2000 Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer. Molecular Genetics and Metabolism 71 315–320. (https://doi.org/10.1006/mgme.2000.3044)
Williams T, Berelowitz M, Joffe S, Thorner M, Rivier J, Vale W & & Frohman LA 1985 Impaired growth-hormone responses to growth hormone-releasing factor in obesity - reply. New England Journal of Medicine 312 1326–1327.
Wolin KY, Carson K & & Colditz GA 2010 Obesity and cancer. Oncologist 15 556–565. (https://doi.org/10.1634/theoncologist.2009-0285)
Wolpin BM, Meyerhardt JA, Chan AT, Ng K, Chan JA, Wu K, Pollak MN, Giovannucci EL & & Fuchs CS 2009 Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. Journal of Clinical Oncology 27 176–185. (https://doi.org/10.1200/JCO.2008.17.9945)
Woods KA, CamachoHubner C, Savage MO & & Clark AJL 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New England Journal of Medicine 335 1363–1367. (https://doi.org/10.1056/NEJM199610313351805)
Wu ZS, Yang K, Wan Y, Qian PX, Perry JK, Chiesa J, Mertani HC, Zhu T & & Lobie PE 2011 Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma. Journal of Clinical Endocrinology and Metabolism 96 E1619–E1629. (https://doi.org/10.1210/jc.2011-1245)
Yamauchi K & & Pessin JE 1994 Insulin-receptor substrate-1 (IRS1) and SHC compete for a limited pool of GRB2 in mediating insulin downstream signaling. Journal of Biological Chemistry 269 31107–31114. (https://doi.org/10.1016/S0021-9258(1847396-6)
Zapf J, Hauri C, Futo E, Hussain M, Rutishauser J, Maack CA & & Froesch ER 1995 Intravenously injected insulin-like growth-factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats. Journal of Clinical Investigation 95 179–186. (https://doi.org/10.1172/JCI117636)
Zhao HB, Jin H, Xian JF, Zhang ZF, Shi JL & & Bai XS 2022a Effect of ketogenic diets on body composition and metabolic parameters of cancer patients: a systematic review and meta-analysis. Nutrients 14. (https://doi.org/10.3390/nu14194192)
Zhao L, Su HZ, Liu XM, Wang HQ, Feng YK, Wang Y, Chen HQ, Dai L, Lai SH, Xu SQ, et al.2022b mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A. Cell and Bioscience 12 183. (https://doi.org/10.1186/s13578-022-00919-y)
Zhou YH, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, et al.1997 A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proceedings of the National Academy of Sciences of the United States of America 94 13215–13220. (https://doi.org/10.1073/pnas.94.24.13215)
Zhu T, Goh ELK, Graichen R, Ling L & & Lobie PE 2001 Signal transduction via the growth hormone receptor. Cellular Signalling 13 599–616. (https://doi.org/10.1016/s0898-6568(0100186-3)
Zhu Y, Wang HK & & DWYe 2013 Visceral obesity and risk of high-grade disease in clinical T1A renal cell carcinoma. Journal of Urology 189 E301–E301.
Online ISSN: 1479-6821
Print ISSN: 1351-0088
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519